2 of 2 Cho's team is already applying the same pipeline beyond the colon. They've begun identifying analogous master regulators in brain cells — a direction with enormous stakes, since the brain is the one organ where conventional destruction-based therapy does the most damage to who you are. Why this is bigger than oncology Every field that matures goes through the same transition. First you solve problems by destruction: you kill the pest, burn the field, delete the file, fire the worker. Then, as your model of the system improves, you graduate to redirection: integrated pest management, regenerative agriculture, version control, retraining. Destruction is what you do when you don't understand the system well enough to steer it. Conversion is what becomes possible when you do. Cancer therapy has been stuck at the destruction stage for a hundred years, not because oncologists lack imagination, but because they lacked the map. You cannot redirect a cell you cannot model. The digital twin is the map. BENEIN is the compass. And once you have those, "kill the tumor" stops being the only verb in the vocabulary. The history of medicine suggests that once a new verb exists, someone eventually learns to conjugate it. The patient as the hero Here's the frame that matters for the reader walking this journey, whether as a patient, a caregiver, or simply someone watching the map of the possible get redrawn: For a hundred years, the cancer patient has been asked to endure the cure. The bargain was explicit and brutal: we will poison you, and we will try to poison the tumor slightly more. Survival meant outlasting your own treatment. Millions did, at a cost written in neuropathy, organ damage, secondary cancers, and years of life spent recovering from being saved. The KAIST result points — distantly, but genuinely — at a future where the bargain changes. Where treatment doesn't ask the patient to survive the cure, because the cure doesn't attack the patient at all. Where the oncologist's job shifts from demolition to guidance: from killing the cells that lost their way to showing them the way back. Not war. Rewiring. It is early. It may fail in translation, as most beautiful mechanisms do. But notice what just happened: the set of thinkable futures got one entry larger. And in a field where the thinkable set has been frozen for a century, that is not a small thing. The cells changed their minds. The question now is whether medicine can change its mind about what healing means. Source: Cho et al., "Control of Cellular Differentiation Trajectories for Cancer Reversion," *Advanced Science*, DOI: 10.1002/advs.202402132.